Meredian, Inc. purchased the intellectual property that forms the basis of its bioplastic technology from Procter & Gamble in 2007, and has continued to improve the patent portfolio with key international and North American patents. Meredian’s founding partners, S. Blake Lindsey and Dr. Daniel T. Carraway, shared the vision of P&G that PHA could provide global markets with a sustainably produced, renewable, biodegradable plastic material at a competitive cost. Meredian PHA has the physical property attributes to serve a wide array of applications challenging the status quo where, until now, petroleum-based plastics were the only option due to performance and price. The Meredian intellectual property holdings currently include multiple patents and patent applications with global coverage.
Meredian, Inc. has been successful to date in raising the required capital for building our teams, labs, pre-pilot and now pilot scale production systems. This has been achieved through a combination of individual investors, strategic customer partners and U.S. Government supported loan programs for businesses, bringing jobs to rural America such as those offered by the USDA-Rural Development and the U.S. Department of Treasury-New Market Tax Credit programs.